NovaCell Technology is Biotechnology in South Korea that focus on bowel disease business. Founded in 2000. They cover business area such as developer, biomaterial, pharmaceutical, contract research service, new drug development, collaborative research product, various other domestic and foreign university, research lab, institution, patient, disease, atopy, asthma.
2000
( 24 years old in 2024 )
Bowel Disease
-
77, Cheongam-ro, Nam-gu
Pohang University of Science and Technology
Pohang-si, Gyeongsangbuk-do
South Korea
Private
developerbiomaterialpharmaceuticalcontract research servicenew drug developmentcollaborative research productvarious other domestic and foreign universityresearch labinstitutionpatientdiseaseatopyasthma
* We use standard office opening hours in near NovaCell Technology's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
NovaCell Technology is Biotechnology business from South Korea that founded in 2000 (24 years old in 2024), NovaCell Technology business is focusing on Bowel Disease.
NovaCell Technology headquarter office and corporate office address is located in 77, Cheongam-ro, Nam-gu Pohang University of Science and Technology Pohang-si, Gyeongsangbuk-do South Korea.
NovaCell Technology was founded in South Korea.
In 2024, NovaCell Technology is currently focus on bowel disease sector.
Above is snippet of Google Trends for "bowel disease" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with NovaCell Technology, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
